<?xml version="1.0" encoding="UTF-8"?>

<CodeSystem xmlns="http://hl7.org/fhir">
  <id value="napkon-pediatrics-module"/>
  <text>
    <status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p>This code system https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/napkon-pediatrics-module defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">000001<a name="napkon-pediatrics-module-000001"> </a></td><td>Sphingosine analogue (substance)</td></tr><tr><td style="white-space:nowrap">000002<a name="napkon-pediatrics-module-000002"> </a></td><td>Substance with interleukin 2 receptor antagonist mechanism of action (substance)</td></tr><tr><td style="white-space:nowrap">000003<a name="napkon-pediatrics-module-000003"> </a></td><td>Substance with interleukin 17 receptor antagonist mechanism of action (substance)</td></tr><tr><td style="white-space:nowrap">000004<a name="napkon-pediatrics-module-000004"> </a></td><td>Anti-CD20 antibody (substance)</td></tr><tr><td style="white-space:nowrap">000005<a name="napkon-pediatrics-module-000005"> </a></td><td>Anti-CD52 antibody (substance)</td></tr><tr><td style="white-space:nowrap">000006<a name="napkon-pediatrics-module-000006"> </a></td><td>Anti-CD3 antibody (substance)</td></tr><tr><td style="white-space:nowrap">000007<a name="napkon-pediatrics-module-000007"> </a></td><td>Anti-CD3/CD19 antibody (substance)</td></tr><tr><td style="white-space:nowrap">000008<a name="napkon-pediatrics-module-000008"> </a></td><td>Substance with Integrin inhibitor mechanism of action (substance)</td></tr><tr><td style="white-space:nowrap">000009<a name="napkon-pediatrics-module-000009"> </a></td><td>Substance with B cell activating factor inhibitor mechanism of action (substance)</td></tr></table></div>
  </text>
  <url value="https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/napkon-pediatrics-module"/>
  <version value="0.1.0"/>
  <name value="NapkonPediatricsModule"/>
  <title value="NapkonPediatricsModule"/>
  <status value="active"/>
  <date value="2021-10-12T12:09:14+00:00"/>
  <publisher value="BIH @ Charité"/>
  <contact>
    <name value="BIH @ Charité"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.netzwerk-universitaetsmedizin.de"/>
    </telecom>
  </contact>
  <description value="NAPKON Pediatrics Module Code System - Collection of pediatrics module-specific codes that are missing from common terminologies such as SNOMED CT"/>
  <content value="complete"/>
  <count value="9"/>
  <concept>
    <code value="000001"/>
    <display value="Sphingosine analogue (substance)"/>
  </concept>
  <concept>
    <code value="000002"/>
    <display value="Substance with interleukin 2 receptor antagonist mechanism of action (substance)"/>
  </concept>
  <concept>
    <code value="000003"/>
    <display value="Substance with interleukin 17 receptor antagonist mechanism of action (substance)"/>
  </concept>
  <concept>
    <code value="000004"/>
    <display value="Anti-CD20 antibody (substance)"/>
  </concept>
  <concept>
    <code value="000005"/>
    <display value="Anti-CD52 antibody (substance)"/>
  </concept>
  <concept>
    <code value="000006"/>
    <display value="Anti-CD3 antibody (substance)"/>
  </concept>
  <concept>
    <code value="000007"/>
    <display value="Anti-CD3/CD19 antibody (substance)"/>
  </concept>
  <concept>
    <code value="000008"/>
    <display value="Substance with Integrin inhibitor mechanism of action (substance)"/>
  </concept>
  <concept>
    <code value="000009"/>
    <display value="Substance with B cell activating factor inhibitor mechanism of action (substance)"/>
  </concept>
</CodeSystem>